Ratios in Focus: Analyzing Novavax, Inc. (NVAX)’s Price-to-Cash and Price-to-Free Cash Flow

In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

In the latest session, Novavax, Inc. (NASDAQ: NVAX) closed at $19.56 down -6.75% from its previous closing price of $20.97. In other words, the price has decreased by -$6.75 from its previous closing price. On the day, 39.12 million shares were traded. NVAX stock price reached its highest trading level at $23.8599 during the session, while it also had its lowest trading level at $19.28.

Ratios:

For a deeper understanding of Novavax, Inc.’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.88 and its Current Ratio is at 0.90.

On May 10, 2024, BofA Securities Upgraded its rating to Neutral which previously was Underperform and also upped its target price recommendation from $4 to $12.

B. Riley Securities Upgraded its Neutral to Buy on August 09, 2023, while the target price for the stock was maintained at $15.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 14 ’24 when Dubovsky Filip sold 47,312 shares for $13.90 per share. The transaction valued at 657,637 led to the insider holds 38,953 shares of the business.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NVAX now has a Market Capitalization of 2880412416 and an Enterprise Value of 2846059520. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.75. Its current Enterprise Value per Revenue stands at 2.856 whereas that against EBITDA is -8.525.

Stock Price History:

Over the past 52 weeks, NVAX has reached a high of $22.24, while it has fallen to a 52-week low of $3.53. The 50-Day Moving Average of the stock is 138.57%, while the 200-Day Moving Average is calculated to be 201.87%.

Shares Statistics:

For the past three months, NVAX has traded an average of 13.33M shares per day and 21395430 over the past ten days. A total of 139.51M shares are outstanding, with a floating share count of 133.32M. Insiders hold about 5.05% of the company’s shares, while institutions hold 56.88% stake in the company. Shares short for NVAX as of 1715731200 were 45291396 with a Short Ratio of 3.40, compared to 1713139200 on 43769652. Therefore, it implies a Short% of Shares Outstanding of 45291396 and a Short% of Float of 39.200002.

Most Popular